CPI-203
CAS No. 202591-23-9
CPI-203 ( —— )
Catalog No. M13155 CAS No. 202591-23-9
CPI-203 is a potent BET bromodomain inhibitor with IC50 of 37 nM for BRD4.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 45 | In Stock |
|
10MG | 68 | In Stock |
|
25MG | 108 | In Stock |
|
50MG | 199 | In Stock |
|
100MG | 358 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCPI-203
-
NoteResearch use only, not for human use.
-
Brief DescriptionCPI-203 is a potent BET bromodomain inhibitor with IC50 of 37 nM for BRD4.
-
DescriptionCPI-203 is a potent BET bromodomain inhibitor with IC50 of 37 nM for BRD4.
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetEpigenetic Reader Domain
-
RecptorBRD4
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number202591-23-9
-
Formula Weight399.90
-
Molecular FormulaC19H18ClN5OS
-
Purity>98%(HPLC)
-
SolubilityDMSO: 200 mM
-
SMILESCC1=C(C)C2=C(S1)N1C(C)=NN=C1C(CC(N)=O)N=C2C1=CC=C(Cl)C=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Devaiah BN, et al. Proc natl Acad Sci U S A. 2012, 109(18), 6927-6932.
molnova catalog
related products
-
Alobresib
Alobresib is an inhibitor of BET bromodomain,is an antineoplastic drug candidate.
-
UNC926 hydrochloride
UNC926 hydrochloride is a?methyl-lysine (Kme) reader domain?inhibitor.
-
EML 425
EML 425 is a potent and selective inhibitor of CREB binding protein (CBP)/p300 (IC50s: 2.9 and 1.1 μM, respectively).